• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Plasticizer Alternative ATBC Promotes Osteosarcoma Progression in Cell Models via EGFR

by
November 13, 2026
in Biology
Reading Time: 5 mins read
0
Plasticizer Alternative ATBC Promotes Osteosarcoma Progression in Cell Models via EGFR

Plasticizer Alternative ATBC Promotes Osteosarcoma Progression in Cell Models via EGFR

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A widely used plasticizer alternative, acetyl tributyl citrate, accelerated osteosarcoma cell proliferation, migration, and invasion under controlled laboratory conditions by engaging epidermal growth factor receptor signaling, according to an integrated investigation published in Frontiers in Cell and Developmental Biology. Investigators evaluated the compound through a combination of network toxicology screening, molecular dynamics simulations, transcriptomic profiling, and in vitro cellular assays. The study specifically sought to clarify whether the common additive, widely adopted as a non-phthalate substitute across consumer products, medical devices, and pharmaceutical coatings, affects malignant behavior in bone cancer cells. While the compound is frequently characterized as an eco-friendly option with lower baseline toxicity than legacy phthalates, the newly reported findings indicate that it can activate oncogenic cascades in cultured human osteosarcoma cell lines, establishing a functional rationale for targeted toxicological evaluation.

Osteosarcoma represents the most common primary malignant bone tumor observed in children and adolescents, predominantly arising near metaphyseal growth plates. Although its overall incidence remains comparatively rare, registering age-standardized rates of 2.9 cases per million in males and 2.2 per million in females, clinical management is severely complicated by aggressive local invasion and a tendency toward early metastatic dissemination. The broader etiology of the malignancy remains incompletely mapped, driven by a confluence of genetic alterations, epigenetic modifications, microenvironmental interactions, and the aberrant activation of signal transduction pathways. While several organic contaminants have previously undergone assessment for carcinogenic potential, the biological activity of specialized modern plasticizers in osteosarcoma pathogenesis has remained largely unaddressed in experimental literature.

Acetyl tributyl citrate has consequently emerged as a primary substitute for di(2-ethylhexyl) phthalate across medical tubing, food packaging films, cosmetics, and oral pharmaceutical formulations, with historical regulatory records noting patient intakes reaching up to 20.2 milligrams daily from coated tablets and capsules. Surging demand for non-phthalate plasticizers elevated the eco-plasticizer market past 3.1 billion dollars in 2021, accompanied by consistent environmental detections in municipal river systems, coastal seawater, indoor air dust, and packaged foodstuffs. Despite this commercial expansion, recent toxicological investigations have linked the substance to disrupted thyroid hormone regulation, enhanced adipogenesis, and inhibition of healthy osteoblast migration, prompting questions regarding its broader cellular safety.

To map potential molecular targets of acetyl tributyl citrate, the research team queried multiple computational repositories, including ChEMBL, SwissTargetPrediction, STITCH, and the Similarity Ensemble Approach, identifying 410 candidate proteins associated with the chemical structure. Concurrently, they assembled 5,738 osteosarcoma-related targets by combining records from GeneCards, OMIM, and the Therapeutic Target Database with differentially expressed genes extracted from public Gene Expression Omnibus transcriptomic datasets, specifically GSE16091 and GSE99671. Intersecting the chemical and disease target libraries yielded 226 overlapping candidate genes. Subsequent protein-protein interaction network construction using the STRING database and Cytoscape topological analysis ranked the epidermal growth factor receptor as the central topological hub exhibiting the highest degree of network connectivity, marking it as the primary candidate for downstream pathway analysis.

Functional enrichment analyses performed on the 226 shared targets delineated broad pathway-level involvement across oncogenic signaling cascades. Gene Ontology assessments identified 2,187 statistically significant enriched terms across biological processes, cellular components, and molecular functions, highlighting chemokine-mediated signaling, cell surface membrane complexes, and protein tyrosine kinase activities. Pathway mapping through the Kyoto Encyclopedia of Genes and Genomes demonstrated significant enrichment across 184 signaling networks, led by the PI3K-Akt, mitogen-activated protein kinase, ErbB, and Ras pathways. These enrichment patterns aligned closely with the established signaling biology of the epidermal growth factor receptor, a transmembrane tyrosine kinase known to orchestrate cell survival, growth, and invasion upon ligand binding and subsequent cascade stimulation.

To evaluate whether acetyl tributyl citrate can physically dock with the receptor, investigators conducted computational molecular docking using the crystallographic structure of the epidermal growth factor receptor kinase domain cataloged under Protein Data Bank identifier 1M14. AutoDock Vina calculations identified a favorable binding pose within the receptor pocket, which was subsequently subjected to a 100-nanosecond all-atom molecular dynamics simulation in GROMACS using the CHARMM36 force field. Trajectory tracking revealed structural stability throughout the 100-nanosecond timeline, with backbone root-mean-square deviations fluctuating stably within a narrow range between 0.15 and 0.30 nanometers. Protein compactness was preserved, exhibiting a total radius of gyration of approximately 1.9 nanometers, a constant solvent-accessible surface area averaging roughly 155 square nanometers, persistent intermolecular hydrogen bonding, and a free energy landscape converging on a dominant conformational minimum.

Expanding upon the computational framework, the investigators examined regulatory gene networks co-expressed with the receptor across osteosarcoma transcriptomes, isolating candidates meeting correlation coefficients exceeding 0.4. Differential expression validation across datasets confirmed significant upregulation for genes including SUMO1, MAPRE3, and RBX1. Using an exploratory machine learning pipeline encompassing Random Forest, Support Vector Machine, and LASSO regression algorithms across 74 clinical tissue samples, the authors tested diagnostic discrimination between tumor specimens and non-tumor controls. A Random Forest model constructed on the candidate panel yielded an area under the receiver operating characteristic curve of 0.989 in the training cohort, with SHapley Additive exPlanations highlighting contributions from candidates such as ZNF271. Furthermore, deconvolution of immune infiltration via single-sample gene set enrichment and CIBERSORT revealed significant shifts in immune cell subsets, including reductions in infiltrating macrophages, neutrophils, and dendritic cells alongside increased CD56dim natural killer cells in tumor specimens.

Direct experimental validation was conducted in vitro utilizing two authenticated human osteosarcoma cell lines, designated HOS and 143B. Cell viability profiling through CCK-8 colorimetric assays across a gradient of acetyl tributyl citrate concentrations revealed a dose-responsive stimulation of cell growth that peaked at 75 micromolar, followed by an attenuation of the pro-proliferative response at 100 micromolar. Exposure to the 75-micromolar concentration consistently amplified cellular DNA synthesis as measured by EdU incorporation, enhanced colony formation over seven days of culture, and intensified immunofluorescence staining for the proliferation marker Ki-67. Transwell migration, Matrigel invasion, and wound-healing scratch assays further demonstrated that treatment with the plasticizer significantly heightened the motile and invasive capacity of the osteosarcoma cells over a 24-hour observation period.

Western blot analysis of treated osteosarcoma cells demonstrated that exposure to acetyl tributyl citrate increased the abundance of epidermal growth factor receptor protein and proliferating cell nuclear antigen, accompanied by elevated phosphorylation of the downstream kinase AKT without altering total AKT protein levels. To confirm whether the observed phenotypic enhancement depended directly on receptor function, researchers constructed stable knockdown cell lines transduced with lentiviral short hairpin RNA vectors targeting the receptor. Suppressing receptor expression effectively eliminated the plasticizer-induced increases in proliferating cell nuclear antigen levels, colony growth, EdU incorporation, and Transwell cell motility. When the AKT activator compound SC79 was co-administered to receptor-depleted cells in rescue experiments, both proliferative marker expression and invasive motility were partially restored, confirming that AKT functions as a key downstream effector within the axis.

The study authors emphasized critical methodological limitations, noting that all functional findings were derived strictly from in vitro cell models and computational predictions. The nominal 75-micromolar concentration applied in culture medium was chosen to establish an interpretable phenotypic response in vitro and cannot be directly equated to human blood or bone tissue concentrations, as complete absorption, distribution, metabolism, and excretion data remain unavailable. Additionally, machine learning analyses were designated as exploratory due to platform batch adjustments conducted prior to data partitioning, and direct biochemical binding affinities were not experimentally measured. The researchers concluded that while the compound promotes malignant phenotypes through receptor-dependent signaling in isolated cellular settings, systematic in vivo toxicological studies and rigorous epidemiological monitoring are required before public health risks or regulatory exposure limits can be established.

Subject of Research: Evaluation of acetyl tributyl citrate effects on osteosarcoma cells via EGFR signaling

Article Title: Acetyl tributyl citrate promotes osteosarcoma progression via EGFR/AKT signaling: an integrated network toxicology and experimental study

Article References: Jiang, P., Luo, C., Lu, T., Chen, T., Liang, G., Pu, X., & Lu, S. (2026). Acetyl tributyl citrate promotes osteosarcoma progression via EGFR/AKT signaling: an integrated network toxicology and experimental study. Frontiers in Cell and Developmental Biology, 14, Article 1965968. https://doi.org/10.3389/fcell.2026.1965968

Image Credits: AI Generated

DOI: 10.3389/fcell.2026.1965968

Keywords: acetyl tributyl citrate, osteosarcoma, epidermal growth factor receptor, plasticizers, network toxicology, molecular dynamics, cell proliferation, tumor invasion, AKT phosphorylation, bone neoplasms, environmental toxicology, in vitro assays, cell migration, CIBERSORT, oncogenic signaling, toxicology

News Source: Drew Townsend. (November 13, 2026). Plasticizer Alternative ATBC Promotes Osteosarcoma Progression in Cell Models via EGFR. Scienmag.

Tags: acetyl tributyl citrateAKT phosphorylationbone neoplasmscell migrationCell proliferationCIBERSORTenvironmental toxicologyepidermal growth factor receptorin vitro assaysmolecular dynamicsNetwork toxicologyoncogenic signalingOsteosarcomaplasticizersToxicologytumor invasion
Share12Tweet7Share2ShareShareShare1

Related Posts

Weighted Residual Attention Deep Learning Framework Accelerates Drug-Target Interaction Prediction

Weighted Residual Attention Deep Learning Framework Accelerates Drug-Target Interaction Prediction

November 18, 2026
Cryo-EM Uncovers How Human Nitric Oxide Synthase Coordinates Intermonomer Electron Transfer

Cryo-EM Uncovers How Human Nitric Oxide Synthase Coordinates Intermonomer Electron Transfer

November 18, 2026

Epithelial Exosomal miR-124 Regulates Endothelial Cell Apoptosis in COPD via RhoA Pathway

November 18, 2026

Melatonin May Mitigate Health Risks From Emerging Environmental Contaminants

November 18, 2026

POPULAR NEWS

  • Elite Luge Athletes Experience Seasonal Shifts in Body Composition and Biomarkers

    Elite Luge Athletes Experience Seasonal Shifts in Body Composition and Biomarkers

    29 shares
    Share 12 Tweet 7
  • Olive Oil Supplementation Remodels Plasma Lipids and Metabolites in Aged Tauopathy Mice

    29 shares
    Share 12 Tweet 7
  • Mitophagy Inhibitor Ac220 Enhances Magnolol Antitumor Action in Ewing Sarcoma

    29 shares
    Share 12 Tweet 7
  • Systematic Review Finds Long-Term Data Scarce for Chronic Neuropathic Pain Treatments

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Weighted Residual Attention Deep Learning Framework Accelerates Drug-Target Interaction Prediction

Cryo-EM Uncovers How Human Nitric Oxide Synthase Coordinates Intermonomer Electron Transfer

Lecanemab Shows Cognitive Stability and Amyloid Clearance in Chinese Alzheimer’s Cohort

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.